Results 81 to 90 of about 10,795 (199)

Peri‐Implant Soft‐Tissue Phenotype Modification for Refractory Peri‐Implant Mucositis: A 12‐Month Prospective Clinical Study With Ultrasonographic Analysis

Journal of Periodontal Research, EarlyView.
Surgical treatment of refractory peri‐implant mucositis with a free gingival graft (FGG) was effective in disease resolution, achieving reductions in probing pocket depth (PPD) and inflammation. Significant gains in mucosal thickness (MT) and keratinized mucosa width (KMW), as well as partial recession coverage and re‐establishment of attached mucosa ...
Shayan Barootchi, Lorenzo Tavelli, Hamoun Sabri, Hom‐Lay Wang, Erfan Barootchi, Mario Romandini, Istvan A. Urban, Zoltan Barath   +7 more
wiley   +1 more source

The role of acquired host immunity in periodontal diseases

Periodontology 2000, EarlyView.
Abstract The aim of this narrative review is to relate the contribution of European researchers to the complex topic of the host immune system in periodontal disease, focusing on acquired immunity. Other chapters in this volume will address the genetics and autoantibody responses and other forms of immunity to periodontal disease.
Denis F. Kinane, David F. Lappin, Shauna Culshaw   +2 more
wiley   +1 more source

Cyclosporin A and phenytoin modulate inflammatory responses.

, 2009
Gingival overgrowth is a common side-effect of administration of the immunosuppressant cyclosporin A and the anti-epileptic drug phenytoin. While cyclosporin-induced gingival overgrowth is often accompanied by gingival inflammation, phenytoin-induced ...
Kaneko, T, Hara, Y, Suzuki, A M M, Ozaki, Y, Yoshimura, Atsutoshi   +4 more
core   +2 more sources

Epidemiology and Outcomes of Cryptococcal Infections in Liver Transplant Recipients: A Retrospective Cohort Study at a US Academic Center

Transplant Infectious Disease, EarlyView.
Among 346 liver transplant recipients, rural residence conferred a 3.3‐fold higher risk of cryptococcal infection — a novel finding suggesting environmental exposure or healthcare access barriers may drive susceptibility. Triple immunosuppression and longer waitlist duration were additional risk factors, with very early infection carrying the worst ...
Rachel Sigler, Chloe Hanigan, Atikur Rahman, Isuru Ratnayake, Phani Akella, Lauren Carlini, Chelsea Gorsline, Erica Mackenzie, Albert Eid, Dennis Shoemaker, Ryan Taylor, Stephen Waller   +11 more
wiley   +1 more source

Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus

Nefrología (English Edition), 2015
Background: Switching to cyclosporin A may result in a reversion of tacrolimus-induced diabetes mellitus. However, mechanisms underlying such a reversion are still unknown.
Ana Elena Rodríguez-Rodríguez, Javier Triñanes, Esteban Porrini, Silvia Velázquez-García, Cecilia Fumero, María Jose Vega-Prieto, María Luisa Díez-Fuentes, Sergio Luis Lima, Eduardo Salido, Armando Torres   +9 more
doaj   +1 more source

Interaction of cyclosporin A with human lipoproteins

, 1986
The ultracentrifugal fractionation of human serum after previous incubation with cyclosporin A showed that, in healthy fasting individuals, 8% of cyclosporin A was found in the very low density lipoproteins (VLDL), 31% in the low density lipoproteins ...
Demetrios Sgoutas, Ann Love, Wendy Macmahon, Ivanka Jerkunica   +3 more
core   +1 more source

Serum Eosinophil‐Derived Neurotoxin (EDN) as a Biomarker for Treatment Response in Atopic Dermatitis

Clinical &Experimental Allergy, EarlyView.
J. I. Olydam, S. Sengkerij, S. Veenbergen, D. J. Hijnen   +3 more
wiley   +1 more source

Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility

, 2011
Yang Lei1,2, Yi Lu2, Jianping Qi2, Sufang Nie1, Fuqiang Hu3, Weisan Pan1, Wei Wu21School of Pharmacy, Shenyang Pharmaceutical University, Shenyang; 2School of Pharmacy, Fudan University, Shanghai; 3School of Pharmacy, Zhejiang University, Hangzhou ...
Nie S, Hu F, Pan W, Qi J, Lu Y, Lei Y, Wu W   +6 more
core  

Concurrent clarithromycin and cyclosporin A treatment [PDF]

, 1998
Although macrolides have been associated with significant pharmacokinetic interactions, clarithromycin is considered to have a low interaction capacity. In this study, six transplant recipients treated with cyclosporin A also received
Azanza, J.R. (José Ramón), Lopez-de-Ocariz, A. (A.), Álvarez-Cienfuegos, J. (Javier), Sadaba, B. (Belén), Quiroga, J. (Jorge)   +4 more
core  

Biodistribution of Cyclosporin Encapsulated in Liposomes Modified with Bioadhesive Polymer

, 1997
The purpose of this investigation was to study the possibility of renewing the immunosuppressive activity of cyclosporin by formulating the compound in liposomes modified with bioadhesive polymers.
Kanji Takada, Takeshi Houjou, Yutaka Komuta, Hiroshi Yoshikawa, Yukako Yoshikawa, Masaya Miyazaki   +5 more
core   +1 more source